Keywords: losartan, approved, uk, hypertension, merck, co, subsidiary

Losartan Approved In UK For Hypertension

Article | 16 January 1995

Print This

Merck & Co's UK subsidiary Merck Sharp & Dohme has received approval to market its new angiotensin II receptor antagonist, Cozaar (losartan) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in